Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 8.31%
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.15
Flat results in Sep 25
With ROE of 6, it has a Expensive valuation with a 2.4 Price to Book Value
Below par performance in long term as well as near term
Stock DNA
Castings & Forgings
INR 51 Cr (Micro Cap)
40.00
35
0.00%
-0.06
6.04%
2.38
Total Returns (Price + Dividend) 
Smiths & Founder for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Smiths & Founder Sees Revision in Market Evaluation Amidst Challenging Fundamentals
Smiths & Founder, a microcap player in the Castings & Forgings sector, has experienced a revision in its market evaluation reflecting a more cautious analytical perspective. This shift is driven by a combination of factors spanning quality, valuation, financial trends, and technical outlook, underscoring the complexities facing the company in the current market environment.
Read More
Smiths & Founders (India) Stock Hits 52-Week Low at Rs.4.6
Smiths & Founders (India) touched a fresh 52-week low of Rs.4.6 today, marking a significant price level for the castings and forgings company amid a challenging market environment and subdued financial indicators.
Read More
Smiths & Founders (India) Stock Hits 52-Week Low at Rs.4.6
Smiths & Founders (India) has reached a new 52-week low of Rs.4.6, marking a significant price level for the castings and forgings company amid a challenging market environment. The stock’s recent performance contrasts sharply with broader market trends, reflecting ongoing concerns about its financial metrics and valuation.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
04-Nov-2025 | Source : BSEPlease Find Attached the Un-audited Financial Results as on 30.09.2025 in the Newspapers viz.- Kannada Prabha and Business Standard.
Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 03.11.2025
03-Nov-2025 | Source : BSEThe Board of Directors of the Company at its meeting held today have inter-alia considered and approved the Unaudited Financial Results for the quarter and half year ended 30.09.2025. Please note that the results are appended with the Statement of Assets & Liabilities Cash Flow Statement and Report of Statutory Auditors. The meeting commenced at 12.00 Noon and concluded at 2.10 PM. Kindly take this on your records.
Unaudited Financial Results Along With Statement Of Assets And Liabilities And Cash Flow Statement For Quarter And Half Year Ended 30.09.2025
03-Nov-2025 | Source : BSEPFA the Financial results for the Quarter and half year ended 30.09.2025
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Suresh Shastry (28.64%)
Supriya Shastry (18.27%)
10.45%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 18.27% vs -0.62% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -11.54% vs -29.73% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 4.60% vs 20.36% in Sep 2024
Growth in half year ended Sep 2025 is -25.37% vs 148.15% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is 16.63% vs 10.19% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 181.08% vs 48.00% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 13.38% vs 11.47% in Mar 2024
YoY Growth in year ended Mar 2025 is 66.67% vs 162.50% in Mar 2024






